N. Simon

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

N. Kucher, G. Colucci, M. Schindewolf, 2022, The Lancet Haematology.

Association of Frailty with Adverse Outcomes in Patients with Suspected COVID-19 Infection

R. Bingisser, S. Tschudin-Sutter, M. Siegemund, 2021, Journal of clinical medicine.

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

N. Kucher, G. Colucci, R. Bingisser, 2022, Thrombosis Research.

Diagnoses made in an Emergency Department in rural sub-Saharan Africa.

M. Weisser, D. Paris, M. Rohacek, 2019, Swiss medical weekly.

Can severe acute pain escape visual analog scale screening in the ED?

B. Coudert, J. Cantineau, S. Bataille, 2004, The American journal of emergency medicine.

[Acute severe pain in emergencies. The key for efficient analgesia].

B. Coudert, J. Cantineau, S. Bataille, 2001, Annales francaises d'anesthesie et de reanimation.

Nonspecific complaints in emergency medicine: contribution of clinical chemistry and diagnostic imaging to final diagnosis. An observational study

R. Bingisser, C. Nickel, Annalea Patzen, 2021 .

Emergency presentations of older patients living with frailty: Presenting symptoms compared with non-frail patients.

R. Bingisser, C. Nickel, N. Simon, 2022, The American journal of emergency medicine.

Direct Comparison of Clinical Characteristics, Outcomes, and Risk Prediction in Patients with COVID-19 and Controls—A Prospective Cohort Study

K. Rentsch, R. Bingisser, S. Tschudin-Sutter, 2021, Journal of clinical medicine.